We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Regenerative Medicine Cases Using Adult Stem Cells are Available at www.AutologousAdultStemCells.org
News

Regenerative Medicine Cases Using Adult Stem Cells are Available at www.AutologousAdultStemCells.org

Regenerative Medicine Cases Using Adult Stem Cells are Available at www.AutologousAdultStemCells.org
News

Regenerative Medicine Cases Using Adult Stem Cells are Available at www.AutologousAdultStemCells.org

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Regenerative Medicine Cases Using Adult Stem Cells are Available at www.AutologousAdultStemCells.org"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ronald Trahan Associates (RTA) Inc. has announced the availability of several podcasts at www.AutologousAdultStemCells.org that show how clinicians and researchers from around the world are using autologous adult stem cells to treat cardiovascular, orthopedic and vascular indications at a patient’s point-of-care.

With last night’s airing on “Nightline” of the use of adult stem cells for difficult orthopedic procedures coming on the heels of a recently announced $250 million federal government initiative to fund adult stem cell therapies for treating injured troops returning from Iraq and Afghanistan, the public’s interest in these important cells is high.

Until recently, it has been difficult to process and concentrate a clinically significant dose of adult stem cells from a patient’s own bone marrow at the point-of-care. The podcasts discuss how physicians are making use of new technology to overcome this hurdle.

Advertisement